Masimo is a U.S.-based healthcare technology company specializing in noninvasive patient monitoring, hospital automation, and connected medical devices. The company has raised a total of $110 million across multiple funding rounds, including a $10M Series A, $20M Series B, $30M Series C, and $50M Series D, backed by investors such as Sequoia Capital, Kleiner Perkins, General Catalyst, and Accel Partners. The funding supported product innovation in pulse oximetry, wearable monitoring, telehealth platforms, and hospital-grade medical technologies that improve patient outcomes and reduce healthcare costs.